ABSTRACT: Gonadotropin-inhibitory hormone (GnIH) acts as a negative regulator of reproduction by acting on gonadotropes and gonadotropin-releasing hormone (GnRH) neurons. Despite its functional significance, the molecular mechanism of GnIH action in the target cells has not been fully elucidated. To expand our previous study on GnIH actions in gonadotropes, we investigated the potential signal transduction pathway that conveys the inhibitory action of GnIH in GnRH neurons by using the GnRH neuronal cell line, GT1-7. We examined whether GnIH inhibits the action of kisspeptin and vasoactive intestinal polypeptide (VIP), positive regulators of GnRH neurons. Although GnIH significantly suppressed the stimulatory effect of kisspeptin on GnRH release in hypothalamic culture, GnIH had no inhibitory effect on kisspeptin stimulation of serum response element and nuclear factor of activated T-cells response element activities and ERK phosphorylation, indicating that GnIH may not directly inhibit kisspeptin signaling in GnRH neurons. On the contrary, GnIH effectively eliminated the stimulatory effect of VIP on p38 and ERK phosphorylation, c-Fos mRNA expression, and GnRH release. The use of pharmacological modulators strongly demonstrated the specific inhibitory action of GnIH on the adenylate cyclase/ cAMP/protein kinase A pathway, suggesting a common inhibitory mechanism of GnIH action in GnRH neurons and gonadotropes
Gonadotropin-inhibitory hormone (GnIH) was initially isolated from Japanese quail hypothalamus. The first function identified for GnIH was inhibition of gonadotropin release from the anterior pituitary; this was the first demonstration of a hypothalamic neuropeptide directly inhibiting gonadotropin release in any vertebrate (1) . GnIH peptides have since been identified in all vertebrate classes, and these share an LPXRFamide (X = L or Q) motif at their C-termini (2) (3) (4) . In mammals, GnIH precursor cDNAs encode at least 2 GnIHs [also known as RFamide-related peptides (RFRPs)], RFRP1 and 3 (2) (3) (4) . The mammalian GnIHs inhibit gonadotropin synthesis and/or release across all mammalian species investigated. Thus, the mammalian GnIHs, RFRP1 and RFRP3, appear to act as key neurohormones to inhibit gonadotropin secretion (2) (3) (4) .
Two G protein-coupled receptors (GPCRs), GPR147 and GPR74, have been identified as GnIH receptors (GnIH-Rs) (5, 6) . As a result of the higher GnIH binding affinity for GPR147 than GPR74, GPR147 is thought to be the principal receptor for GnIH (6) . GnIH-Rs couple to Gai, which inhibits the activity of adenylate cyclase (AC), thus reducing intracellular cAMP levels and protein ABBREVIATIONS: AC, adenylate cyclase; CRE, cAMP-response element; FSK, forskolin; GnIH, gonadotropin-inhibitory hormone; GnIH-R, GnIH receptor; GF, GF 109203X; H89, H-89 dihydrochloride; NFAT-RE, nuclear factor of activated T-cell response element; PACAP, pituitary adenylate cyclase-activating polypeptide; PMA, phorbol 12-myristate 13-acetate; RE, response element; RFRP, RFamide-related peptide; RIA, radioimmunoassay; SAPK, stress-activated kinase; SCN, suprachiasmatic nucleus; SRE, serum response element; VIP, vasoactive intestinal polypeptide; VPAC2, VIP/PACAP receptor subtype 2 kinase A (PKA) activity (7) . Cell bodies of GnIH neurons are located in the dorsomedial hypothalamic area in most mammals, and GnIH neurons project to the median eminence to control anterior pituitary function via GnIHRs expressed in gonadotropes (2) (3) (4) . Our recent study using an immortalized gonadotrope cell line LbT2 has demonstrated that the inhibitory action of GnIH on gonadotropin gene expression is mediated by an inhibition of AC/cAMP/PKA-dependent extracellular signal regulated kinase (ERK) pathway (8) .
In addition to the effect of GnIH on the pituitary, the projection of GnIH neurons to GnRH neurons was first demonstrated in birds (9) and is perhaps the most conserved property of GnIH. GnIH neuronal axon terminals contact GnRH neurons that express GPR147 in the preoptic area in mammals (10) (11) (12) (13) . Direct application of GnIH to hypothalamic brain slices decreased the firing rate of a subpopulation of GnRH neurons (14) , supporting a direct suppressive effect of GnIH on GnRH neurons. Furthermore, electrophysiological recordings suggested that a direct postsynaptic inhibition of GnRH neuronal firing may occur via GnIH-mediated hyperpolarization of K + channels in vGluT2-GnRH neurons (15) . Similarly, intracerebroventricular administration of GnIH suppressed c-Fos immunoreactivity in GnRH neurons, which is a widely used marker for the anatomic identification of neuronal activation (16) . Together, these findings point to a potent inhibitory role for GnIH in the regulation of GnRH neurons, although the detailed mechanisms underlying the inhibitory effect of GnIH on GnRH neurons have not been fully characterized.
The neuropeptide kisspeptin, the product of Kiss-1 gene, acts as a key stimulatory regulator of the GnRH system and is critical for reproductive function. Kisspeptin neurons make close contact with GnRH neurons acting at both the cell body and the nerve terminals (17, 18) . The majority of GnRH neurons express the receptor for kisspeptin, GPR54 (19) , which couples to Gaq to activate phospholipase C and Ca 2+ mobilization (20) . Numerous studies have shown that kisspeptin directly stimulates GnRH neurons, leading to enhanced GnRH secretion and subsequent gonadotropin secretion (21 and references therein). Likewise, kisspeptin treatment potently activates electrical firing of GnRH neurons in hypothalamic slices (22, 23) . From the opposite effects of GnIH and kisspeptin on the GnRH neuronal system, the interaction of their signal transduction pathways is expected to control the GnRH neuronal activity.
Neurons synthesizing vasoactive intestinal polypeptide (VIP) are located in the suprachiasmatic nucleus (SCN) core subregion and have monosynaptic connections with GnRH neurons (24, 25) . GnRH neurons express the VIP/pituitary adenylate cyclase-activating polypeptide (PACAP) receptor subtype 2 (VPAC2) (26) , which is preferentially coupled to the Gas signal transduction pathway that leads to accumulation of cAMP (27) . VIP can also stimulate the inositol phosphate/Ca 2+ /protein kinase C (PKC) pathway by coupling to Gaq and Gai (28) , depending on the target cells. Several lines of evidence have suggested that VIP plays an important role in the preovulatory LH surge. VIP-targeted GnRH neurons preferentially express c-Fos during the afternoon of the LH surge on the day of proestrus (29, 30) , and blocking VIP signaling via in vivo antisense antagonism abolishes GnRH/ c-Fos activation in ovariectomized, estradiol-treated female rats (31, 32) . Additionally, electrical responses of GnRH neurons to exogenous VIP exhibited peak activity around the predicted onset of the LH surge (33) . Together, these lines of evidence suggest that VIP may facilitate GnRH release that leads to the preovulatory LH surge. On the contrary, GnIH has been shown to have an inhibitory effect on estradiol-induced GnRH/LH surge (16, 34) , suggesting that GnIH may decrease the amplitude of GnRH/LH surge by suppressing VIP stimulation of GnRH neurons.
From the evidence indicating a direct inhibitory role of GnIH on the GnRH neuronal system (14-16), we investigated whether GnIH inhibits the stimulatory signal transduction pathways of GnRH neurons triggered by kisspeptin and VIP. The mechanistic study of signal transduction pathway occurring only in GnRH neurons is not at present possible to perform in vivo because of the complex anatomy of hypothalamus. Thus, we used the GT1-7 cell line, an in vitro model of GnRH-secreting neurons of the hypothalamus (35) , to examine the potential signal transduction pathways involved in GnIH action in GnRH neurons.
MATERIALS AND METHODS
Reagents and cell culture VIP (HSDAVFTDNYTRLRKQMAVKKYLNSILN-NH 2 ; Bachem, Torrance, CA, USA), kisspeptin-10 (YNWNSFGLRF-NH 2 ; AnaSpec, San Jose, CA, USA), forskolin (FSK; Santa Cruz Biotechnology, Santa Cruz, CA, USA), phorbol 12-myristate 13-acetate (PMA; LC Laboratories, Woburn, MA, USA), H-89 dihydrochloride (H89; IC 50 = 135 nM for PKA; Cayman Chemical Company, Ann Arbor, MI, USA), SB203580 (IC 50 = 600 mM for p38; Wako, Osaka, Japan), GF 109203X (GF, IC 50 = 8-20 nM for PKC isoforms; Enzo Life Sciences, Farmingdale, NY, USA), and U0126 (IC 50 = 72 nM for ERK1 and 58 nM for ERK2; Wako) were purchased from the manufacturer. Mouse GnIH orthologs, mRFRP1 (VPHSAANLPLRF-NH 2 ), long form of mRFRP3 (mRFRP3L, VNMEAGTRSHFPSLPQRF-NH 2 ), and short form of mRFRP3 (mRFRP3S, SHFPSLPQRF-NH 2 ) were synthesized with an automated solid-phase peptide synthesizer (PSSM-8; Shimadzu, Kyoto, Japan) as described by Son et al. (8) .
GT1-7 cells (35) were kindly donated by Dr. Pamela Mellon (University of California, San Diego, San Diego, CA, USA). The cells were grown in DMEM (Gibco/Invitrogen, Carlsbad, CA, USA) with 4.5 g/L glucose, L-glutamine, and sodium pyruvate supplemented with containing 10% fetal bovine serum (Gibco/ Invitrogen) and 1% penicillin/streptomycin antibiotics (Gibco/ Invitrogen) in a humidified 5% CO 2 atmosphere at 37°C.
Hypothalamic culture and radioimmunoassay of GnRH
Brains from C57BL/6J mice (male, 8 wk; young female, 2-3 mo, and middle-aged female, 9-11 mo) were isolated and the preoptic area/hypothalamic regions were collected into Medium 199 (Gibco/Invitrogen) and preincubated for 1 h at 37°C in an atmosphere of 80% O 2 and 5% CO 2 and nitrogen. Samples were then transferred to a 24-well plate, with each well containing 1 ml of the medium supplemented with vehicle or reagents. After incubation, GnRH levels in culture medium were determined by radioimmunoassay (RIA) using the synthetic human LHRH (Peptide Institute, Osaka, Japan) as a reference standard, [ -LHRH (specific activity: 2200 Ci/mmol; PerkinElmer Life Sciences, Boston, MA, USA) as a radioligand, and polyclonal rabbit anti-mammalian LHRH serum (Cosmo Bio, Tokyo, Japan) as an antibody. The RIA was performed employing a double antibody method as described previously (36) . The antimammalian LHRH antibody at a final dilution of 1:1,000,000 exhibited the ability to specifically bind 52% of the added radioligand in the absence of any unlabeled human LHRH. The sensitivity of the RIA was 1.7 6 0.4 pg/ml assay buffer. The interassay and intra-assay coefficients of variation were 4.2 and 2.7%, respectively.
Response element luciferase reporter assay
Response element (RE) assays were used to investigate the activation of various REs for cAMP (CRE), serum (SRE), and nuclear factor of activated T-cells (NFAT-RE), which allow identification of GPCR pathways, including cAMP production, ERK/MAPK phosphorylation (principally considered PKC-mediated activation), and intracellular Ca 2+ mobilizations, respectively (37 , and 5 ng of pRL-null (Renilla luciferase reporter; Promega) using FuGene HD Transfection Reagent (Promega) according to the manufacturer's instructions. When necessary, the cells were transfected with 100 ng of expression vectors for GPR147, VPAC2, and/or GPR54 (OriGene Technologies, Rockville, MD, USA), and the total amounts of transfected DNA were kept constant by adding appropriate amounts of empty expression vector for control. For construction of GPR147 and VPAC2 expression vectors, full length of the receptors was amplified by PCR from mouse diencephalon cDNA, then PCR products were inserted into a pcDNA3 expression vector (Invitrogen). All constructs were verified by DNA sequencing. After transfection, cells were starved for 24 h in serumfree DMEM and then challenged with vehicle or reagents in various combinations for 6 h to allow accumulation of luciferase mRNA/protein. Cells were then extracted, and luciferase activity was measured using the dual-luciferase reporter assay system (Promega). The ratio of firefly luciferase activity to Renilla luciferase activity was used as the results to coordinate the differences in transfection efficiency among samples.
Protein extraction and Western blot analysis
GT1-7 cells were grown to 80% confluence in 6-well plates. After starvation for 24 h in serum-free DMEM, cells were treated with vehicle or reagents in various combinations. Cells were then lysed in radioimmunoprecipitation assay buffer (Sigma-Aldrich, St. Louis, MO, USA) supplemented with protease inhibitor cocktail (Nacalai USA, San Diego, CA, USA). Equal amounts of protein samples were precleared by centrifugation (15,000 rpm for 10 min at 4°C) and separated by 12.5% SDS-PAGE gel. After electrotransfer onto PVDF membrane, detection of phosphorylated MAPKs was achieved by using either a rabbit polyclonal anti-phosphorylated ERK antibody (Cell Signaling, Danvers, MA, USA), anti-phosphorylated p38 antibody (Cell Signaling), or anti-phosphorylated c-Jun N-terminal kinase [also to a stressactivated kinase (SAPK), JNK/SAPK; Cell Signaling] at 1:3000, followed by a horseradish peroxidase-conjugated anti-rabbit IgG secondary antibody (Santa Cruz Biotechnology) at 1:10,000. Antibodies for total ERK (1:5000; Cell Signaling) and b-tubulin (1:5000; Cell Signaling) were used as loading controls. Detection was accomplished by using the Amersham ECL Plus TM Western Blotting Detection Reagent (GE Healthcare, Piscataway, NJ, USA).
RNA extraction and quantitative real-time PCR analysis
GT1-7 cells were grown to 80% confluence in 6-well plates. After starvation for 24 h in serum-free DMEM, cells were treated with vehicle or reagents in various combinations. Total RNA was extracted by using RNeasy Mini kit (Qiagen, Hilden, Germany) with DNase digestion (RNase-Free DNase Set; Qiagen) according to the manufacturer's instruction. Extracted total RNA was subjected to reverse transcription using Prime Script RTase (Takara, Shiga, Japan). Quantitative real-time PCR was conducted by using the StepOnePlus Real-Time PCR System (Applied Biosystems, Foster City, CA, USA) for mouse c-Fos. The reaction mixture contained Thunderbird SYBR qPCR Mix (Toyobo, Osaka, Japan), 300 nM of each forward and reverse primers, 136-carboxy-X-rhodamine reference dye (Toyobo), and cDNA (equivalent to 5 ng reverse-transcribed RNA) in a final volume of 20 ml. All samples were analyzed in duplicate with the following protocol: 95°C for 1 min, followed by 40 cycles of 95°C for 15 s, and 60°C for 60 s. An external standard curve was generated by serial 10-fold dilutions of plasmid constructs containing the relevant sequences. The PCR products were subjected to a melting curve analysis, gel electrophoresis, and DNA sequencing to confirm the specificity of amplification. The housekeeping gene GAPDH was used for the internal standard. The sequences of the primers were as follows: c-Fos-F: 59-GGCAAAGTAGA-GCAGCTATCTCCT-39 and c-Fos-R: 59-TCAGCTCCCTCCTC-CGATTC-39; GAPDH-F: 59-ACAACTTTGGCATTGTGGAA-39 and GAPDH-R: 59-ACAACTTTGGCATTGTGGAA-39.
Statistical analysis
All results were expressed as means 6 SEM values. Statistical significance was assessed, as indicated in figure legends, by using the GraphPad Prism 4 software (GraphPad Software, La Jolla, CA, USA). Data were analyzed either by 1-way ANOVA followed by Tukey's or Bonferroni's multiple comparison tests, or 2-way ANOVA followed by a Bonferroni's post hoc test for multigroup comparisons. The F values and degrees of freedom for the ANOVAs and reported possible interactions for the 2-way ANOVAs are provided in figure legends.
RESULTS

GnIH has an inhibitory effect on kisspeptininduced GnRH release in hypothalamic culture
To test whether GnIH affects kisspeptin-induced GnRH release, we measured responses to the synthetic mouse GnIH orthologs, mRFRP1, 3L, and 3S, under kisspeptin stimulation in mouse hypothalamic explants. GnRH release from the isolated hypothalamus was increased in response to kisspeptin with 1 h treatment, but not with 10 min treatment (Fig. 1A) . Thus, we treated the hypothalamus from male mice with mRFRPs and kisspeptin for 1 h to examine the inhibitory effect of GnIH on kisspeptininduced GnRH release. Although the inhibitory effects of mRFRP1 and 3L were not significant, 10 26 M of mRFRP3S effectively abolished the stimulatory effect of kisspeptin on GnRH release (Fig. 1B) . GnRH mRNA expression was not changed by 1 h treatment with kisspeptin and/or mRFRPs, and treatment with mRFRPs alone did not affect the basal level of GnRH release (data not shown). These results indicate that GnIH has an inhibitory effect on kisspeptin action in the regulation of GnRH release in hypothalamic culture.
GnIH has no direct inhibitory effect on kisspeptin/GPR54 signaling in GT1-7 cells
To investigate the direct effect of GnIH on kisspeptininduced signaling pathways, we used the GnRH neuronal cell model, GT1-7. First, we confirmed that GT1-7 cells express the 2 GnIH-Rs, GPR147 and GPR74, as well as GPR54 (Supplemental Fig. 1A ), as previously reported (38, 39) . We then examined the functional significance of kisspeptin/GPR54 signaling in GT1-7 cells using the RE reporter assays for CRE, SRE, and NFAT-RE (37) . Because endogenous GPR54 elicited no cellular activity in response to kisspeptin in our GT1-7 culture ( Fig. 2A, empty groups) , we transiently transfected GPR54. By overexpressing GPR54, kisspeptin stimulated SRE and NFAT-RE activities ( Fig. 2A, GPR54 groups) . Although 10 28 M of kisspeptin was able to induce SRE activity, NFAT-RE activity was induced from 10 26 M of kisspeptin (Supplemental Fig. 1C, D) . Thus, we tested the inhibitory effect of GnIH on GT1-7 cells stimulated by these concentrations of kisspeptin. However, mRFRPs did not reduce the kisspeptininduced SRE and NFAT-RE activities, even if GPR147 was overexpressed (Fig. 2B, C) . These results imply that GnIH/GPR147 signaling may not interfere with kisspeptin/GPR54 signaling involved in PKC-mediated ERK pathway (SRE activity) and Ca 2+ release (NFAT-RE activity) in GT1-7 cells.
We also performed Western blot analysis for ERK phosphorylation, which is known as a major cellular signaling event of kisspeptin/GPR54 activation. Kisspeptin caused increased phosphorylation of ERK, which is shown as 2 forms of ERK1 (p44) and ERK2 (p42), when GPR54 was overexpressed (Fig. 2D) . However, this increase was not affected by pretreatment of mRFRPs regardless of GPR147 overexpression, consistent with the result of SRE assay (Fig. 2B) . These results implicate that GnIH may not directly inhibit kisspeptin/GPR54 signaling in GT1-7 neurons.
GnIH inhibits the AC/cAMP-dependent VIP/ VPAC2 signaling in GT1-7 cells
Next, we tested the interaction of GnIH and VIP signaling in GT1-7 cells. As previously reported (40), GT1-7 cells expressed VPAC2 but not VPAC1 (Supplemental Fig. 1A ). GT1-7 cells exposed to 10 26 M of VIP showed 2.7-fold increase in CRE activity, indicating activation of the AC/ cAMP pathway ( Fig. 3A and Supplemental Fig. 1E ). In contrast, VIP failed to induce SRE and NFAT-RE activities. Because VPAC1 was not detected in GT1-7 cells, this VIPinduced CRE activity was considered to be a result of VPAC2 activation. Although overexpression of VPAC1 in GT1-7 cells resulted in activation of both CRE and SRE activity by VIP, VIP specifically induced CRE activity when VPAC2 was overexpressed (data not shown). These results indicate that VIP specifically activates the AC/ cAMP pathway though VPAC2 in GT1-7 cells.
We then examined the effect of GnIH on VIP/VPAC2 signaling by coadministration of mRFRPs and VIP. Although mRFRPs significantly reduced VIP-induced CRE activity, their effects were weak (Fig. 3B, white bars) . However, overexpression of GPR147 completely abolished the effect of VIP (Fig. 3B, black bars) . Notably, mRFRPs alone did not alter basal CRE-luciferase activity, even if GPR147 was overexpressed (Fig. 3B) . We further examined dose-dependent responses of mRFRPs in GPR147-overexpressed condition. The inhibitory effects by all mRFRPs on VIP-induced CRE activity occurred at a concentration of 10 28 M or higher ( Fig. 3C-E) .
VIP/VPAC2 signaling involves p38 and ERK pathways in GT1-7 cells
To investigate the involvement of downstream signaling pathways of VIP/VPAC2 in GT1-7 cells, we conducted Western blot analysis (Scion imaging software; Frederick, MD, USA) using antibodies against MAPK proteins, such as p38, ERK, and JNK/SAPK (Fig. 4) . p38 showed basal phosphorylation in GT1-7 cells, which was increased by VIP. ERK was also phosphorylated in response to VIP. It should be noted that both p38 and ERK showed rapid response to VIP after 1 min of treatment. SAPK/JNK, which typically occurs as multiple bands due to alternate splicing of long (p54) and short (p46) forms, exhibited slight basal phosphorylation, but did not respond to VIP. These results indicate that VIP/VPAC2 signaling targets p38 and ERK phosphorylation in GT1-7 cells.
GnIH inhibits VIP-induced p38 and ERK phosphorylation via AC/cAMP/PKA pathway We further examined the inhibitory effect of GnIH on p38 and ERK phosphorylations in GT1-7 cells. Phosphorylation of p38 in response to VIP was abolished by pretreatment with mRFRP3L and 3S at the concentrations of 10 27 and 10 26 M (Fig. 5A , middle and right panels). Although 10 26 M of mRFRP1 showed a tendency to decrease p38 phosphorylation, it was not statistically significant (Fig. 5A, right panel) . The use of a pharmacological inhibitor H89, which is specific to PKA inhibition, resulted in an inhibition of VIP-induced p38 phosphorylation (Fig.  5B) . In contrast to H89, VIP-induced p38 phosphorylation was not affected by PKC inhibitor GF, and basal p38 phosphorylation was rather stimulated by GF (Fig. 5C) . These results suggest that the effect of GnIH to suppress the stimulatory effect of VIP on p38 activation depends on the PKA pathway.
Next, the effect of GnIH on ERK phosphorylation by VIP was evaluated. As shown in Fig. 5E , mRFRP3S significantly inhibited VIP-induced ERK phosphorylation from 10 27 M and mRFRP3L also inhibited at 10 26 M; however, mRFRP1 had no inhibitory effect even at 10 26 M, which was the same as their effects on p38 phosphorylation. Both inhibitors H89 and GF effectively blocked the stimulatory effect of VIP on ERK phosphorylation (Fig. 5F,  G) , indicating the involvement of both PKA and PKC pathways in VIP-induced ERK phosphorylation in GT1-7 cells. mRFRPs alone did not alter basal p38 and ERK phosphorylation (Fig. 5D, H) .
To identify the pathway responsible for conveying the inhibitory signal of GnIH on ERK phosphorylation, we pharmacologically activated PKA and PKC pathways by FSK, which raise cAMP level by activating AC, and PMA, which activates PKC, respectively, and tested the effects of GnIH (Fig. 6A, B) . We found that FSK-induced ERK phosphorylation was inhibited by 10 26 M of mRFRP3L and 3S (Fig. 6A) . Especially mRFRP3S completely abolished ERK phosphorylation with similar extent of inhibition by PKA inhibitor H89, whereas mRFRP1 had no effect (Fig. 6A, right panel) . In contrast, PKC-mediated ERK phosphorylation induced by PMA was not inhibited by any concentration of mRFRPs (Fig. 6B) . Overexpression of GPR147 did not affect the inability of mRFRPs to inhibit PKC-mediated ERK phosphorylation (data not shown). These results indicate that GnIH specifically inhibits VIPinduced p38 and ERK activation via the AC/cAMP/PKA pathway. It is noteworthy that kisspeptin-induced ERK phosphorylation was solely dependent on the PKC Figure 2 . GnIH has no inhibitory effect on the signaling pathways triggered by kisspeptin in GT1-7 cells. A) RE luciferase (RE-Luc) reporter assays for kisspeptin. Each reporter plasmid (CRE, SRE, or NFAT-RE) was cotransfected with GPR54 or empty vector (empty) in GT1-7, and then treated with vehicle (Vh) or kisspeptin (Kp10, 10
26 M) for 6 h. The relative luciferase activity was measured from cell lysates and expressed as fold activation over the respective basal levels. Each column and the vertical line represent the means 6 SEM (n = 3-5). ***P , 0.001 Vh vs. Kp10 in GPR54 group by 2-way ANOVA followed by Bonferroni's posttests (effect for Kp10 6 GPR54, F 3,26 = 2196.22, P , 0.0001; effect for the RE context, F 2,26 = 1623.45, P , 0.0001; interaction, F 6,26 = 11.36, P , 0.0001). B, C ) Effect of GnIH on kisspeptin-induced SRE or NFAT-RE reporter activities. Each reporter plasmid was cotransfected with GPR54 and GPR147. Kp10 pathway in GT1-7 cells (Supplemental Fig. 2) , supporting no inhibitory effect of GnIH on kisspeptin-mediated ERK activation (Fig. 2D) . From these results, we concluded that GnIH exerts its inhibitory effect via AC/cAMP/PKAspecific pathway.
GnIH inhibits VIP-induced c-Fos expression via PKA pathway, but not basal c-Fos expression mediated by PKC pathway
To investigate the downstream consequence of VIP/ VPAC2-mediated MAPK signaling in GT1-7 cells, we examined the induction of immediate early genes following exposure to VIP. We observed that c-Fos mRNA expression is induced by 10 26 M of VIP after 1 h of treatment (Supplemental Fig. 3A-C) . The mRNA levels of other immediate early genes, such as c-Jun, FosB, JunB, and JunD, were not changed by VIP treatment (data not shown). Overexpressed VPAC2 resulted in more apparent stimulatory effect of VIP ( Supplementary  Fig. 3D , empty vector-transfected, 1.30-fold; VPAC1-transfected, 2.29-fold; VPAC2-transfected, 1.56-fold). Thus, we examined the effect of GnIH on VIP-induced c-Fos expression in VPAC2 overexpressed GT1-7 cells with 1 h treatment. We used mRFRP3S, because mRFRP3S was the most effective inhibitor of p38 and ERK phosphorylations (see Figs. 5A, E, and 6A). To clearly test the function of mRFRP3S, GPR147 was 26 M of VIP (VIP). The relative luciferase activity was measured from cell lysates and expressed as fold activation over the respective basal levels. Each column and the vertical line represent the means 6 SEM (n = 3-5). ***P , 0.001 Vh vs. VIP by 2-way ANOVA followed by Bonferroni's posttests (effect for VIP treatment, F 1,13 = 24.18, P = 0.0001; effect for the RE context, F 2,18 = 42.51, P , 0.0001; interaction, F 2,18 = 42.69, P , 0.0001). B) Effect of GnIH on VIP-induced CRE reporter activity. GT1-7 cells were cotransfected with GPR147 or empty vector (Empty) along with CRE reporter plasmid. Cells were then stimulated by VIP (10 26 M) in the presence or absence of mRFRPs (10 26 M) for 6 h (2, vehicle only). The relative luciferase activity was measured from cell lysates and expressed as fold activation over the respective basal levels. Each column and the vertical line represent the mean 6 SEM (n = 5). ***P , 0.001 vs. cells only stimulated by VIP in empty group by 1-way ANOVA followed by Tukey's multiple comparisons test (F 7,24 = 53.28, P , 0.0001); † † † P , 0.001 Empty vs. GPR147 by 2-way ANOVA followed by Bonferroni's posttests (effect for GPR147, F 1,48 = 40.13, P , 0.0001; effect for VIP 6 mRFRPs, F 7,48 = 66.36, P , 0.0001; interaction, F 7,48 = 7.82, P , 0.0001. C-E) Dose-dependent effect of mRFRP1, 3L, and 3S on VIP-induced CRE activity. GT1-7 cells were cotransfected with CRE reporter plasmid and GPR147. To investigate the upstream pathways that are responsible for c-Fos mRNA expression in GT1-7 cells, we used various pharmacological inhibitors (Fig. 7B) . A similar inhibitory effect as mRFRP3S was observed by PKA inhibitor H89, which only eliminated the stimulatory effect by VIP but not the basal c-Fos expression (Fig. 7C, lanes 3  and 5) . Treatment with SB203580, the inhibitor of p38, whose phosphorylation by VIP is solely dependent on PKA pathway (Fig. 5B, C) , also showed the same inhibitory pattern with H89 and mRFRP3S (Fig. 7C, lanes 4  and 6) . On the contrary, PKC inhibitor GF not only diminished VIP-induced effect but also decreased basal c-Fos expression (Fig. 7C, lanes 7 and 9) . Cotreatment with H89 and GF decreased VIP-induced c-Fos expression more than single treatments by H89 or GF (Fig. 7C, lanes 3 and 7 vs . lane 11), indicating that VIP stimulates c-Fos expression by PKA pathway, whereas PKC pathway is responsible for basal c-Fos expression. The treatment by ERK inhibitor U0126 showed a potent inhibitory effect similar to the combined effect of H89 and GF (Fig. 7C, lanes 8 and 11) , because ERK activation is mediated by both PKA and PKC pathways (Fig. 5F, G) . Taken together, these results reinforce the specific inhibitory effect of GnIH on PKAmediated but not PKC-mediated pathway.
GnIH suppresses the stimulatory effect of VIP on GnRH release in hypothalamic explants of female mice
To determine the physiological relevance of the inhibitory effect of GnIH on VIP-induced signaling shown in GT1-7 cells, we measured GnRH levels released from female mouse hypothalamic explants in response to VIP and GnIH. GnRH release was increased by 1 h treatment of 10 26 M VIP in both young (1.75-fold) and middle-aged (2.17-fold) female mice (Fig. 8) . On the other hand, there was no stimulatory effect of VIP on GnRH release in male mice (vehicle-treated, 45.85 6 6.35 pg/mL, n = 5; VIPtreated, 50.15 6 5.7 pg/mL, n = 5). As shown in Fig. 8 , cotreatment of VIP and mRFRP3S significantly reduced GnRH release induced by VIP in both ages. These results indicate that GnIH may suppress the stimulatory effect of VIP on GnRH release by directly inhibiting VIPinduced signaling pathway in GnRH neurons.
DISCUSSION
The direct regulation of GnRH neurons by GnIH was suggested based on the morphological interaction of GnIH neuronal fibers with GnRH neurons and the existence of GPR147 in GnRH neurons (9) (10) (11) (12) (13) 41) . Several studies have found a suppressive effect of GnIH on the electrical or neuronal activity of GnRH neurons (14) (15) (16) . To understand the direct mechanism of these GnIH actions on GnRH neurons, we used the hypothalamic GnRH-secreting GT1-7 cell line to perform molecular analyses. Our previous study (8) showed that GnIH does not change the basal gene expression of GPCR-mediated cell signaling activities; therefore, we investigated the inhibitory effect of GnIH on the stimulatory regulators acting on GnRH neurons, kisspeptin, and VIP.
Mouse GnIH orthologs
Because the GT1-7 cell is a mouse-derived clone, we wanted to examine the effect of mouse GnIH orthologs, mRFRPs. However, mRFRPs have not been isolated and identified as mature peptides; thus, we synthesized mRFRPs based on their sequence similarities with human RFRPs (hRFRP1 and hRFRP3) that are identified as mature peptides by mass spectrometry (42) . mRFRP1 is similar to hRFRP1, whereas mRFRP3 exhibits low similarity to hRFRP3. There are 2 basic amino acid residues as potential proteolytic cleavage sites in the N-terminal of mRFRP3. Therefore, we synthesized both mRFRP3L (18 aa) and mRFRP3S (9 aa). In CRE reporter assay, there was no distinct difference in the inhibitory capacities of all mRFRPs (Fig. 3C-E) , as shown in our previous study (8) . On the other hand, although mRFRP3L and 3S (especially 3S) effectively eliminated the stimulatory effect of VIP, mRFRP1 only showed a weak inhibitory trend of p38 and ERK phosphorylation (Figs. 5A, E, and 6A). Although the functional differences between mRFRP1 and mRFRP3 remain to be clarified, mRFRP3 may primarily act to inhibit VIP/VPAC2 signaling compared with mRFRP1 in GnRH neurons.
Possibility of GnIH action other than the inhibition of AC/cAMP/PKA pathway
Our studies on GnIH cell signaling in gonadotropes (8) and GnRH neurons (in this study) have also suggested that GnIH specifically inhibits the AC/cAMP/PKA-mediated pathway. On the other hand, it has been reported that GnIH can act on other intracellular pathways. Clarke et al. found that ovine RFRP3 potently blocks the generation of intracellular free Ca 2+ in the pituitary elicited by GnRH, p38 (pp38, A-D) or ERK (pERK, E-H) were detected by Western blot analysis. Equal protein loading was confirmed by stripping the blot and reprobing it with an antibody against b-tubulin or total ERK (ERK). The phosphorylated p38 and ERK were normalized to b-tubulin and total ERK, respectively, and expressed as fold change over the respective basal levels. Each column and the vertical line represent the means 6 SEM (F, G, n = 3; B, C, n = 4). Letters above the (continued on next page) which is essential for the secretion of LH by GnRH in gonadotropes, although they did not directly investigate the site of ovine RFRP3 action within the Ca 2+ system (43). Nichols et al. studied the effect of hRFRP1 in cardiac performance (44) . They showed that hRFRP1 plays important roles in regulating cardiac contraction, but hRFRP3 does not activate the cardiomyocyte signaling pathway (44) . They further demonstrated that the PKC but not PKA inhibitor blocks hRFRP1 activity in cardiomyocytes, suggesting that PKC signaling is activated by hRFRP1 in the cardiomyocyte signaling pathway (44) . Taken together, these studies suggest that RFRPs have a target cell-specific mechanism of action.
Possible inhibitory mechanism of GnIH on kisspeptin-induced GnRH release
Although GnIH (mRFRP3S) effectively suppressed kisspeptin-induced GnRH release in hypothalamic culture of adult mice (Fig. 1B) , all GnIH peptides including mRFRP3S had no inhibitory effect on kisspeptininduced signaling events investigated in GT1-7 cells (Fig. 2) , even though the time course was the same as the VIP experiments. Several possibilities should be considered to understand these conflicting results. Several neuronal networks exist for actions of kisspeptin and GnIH controlling GnRH release in hypothalamic culture, similar to the in vivo environment, compared with GT1-7 cells. In this respect, GnIH may not directly interfere with the stimulatory effect of kisspeptin on GnRH neurons but rather regulate the kisspeptin neuronal activity leading to GnRH release. It has been shown that approximately 25% of kisspeptin neurons in the arcuate nucleus express GPR147 or GPR74, where approximately 35% of arcuate kisspeptin cells received GnIH fiber contacts (45) , suggesting a regulatory role of GnIH/GPR147 signaling in arcuate kisspeptin neurons. Another possibility is that gene expression, such as , and phosphorylated ERK (pERK) was detected by Western blot analysis. Equal protein loading was confirmed by stripping the blot and reprobing it with an antibody against total ERK (ERK). PMA-induced phosphorylation signal was not completely stripped, thus the same protein samples were separated by 2 gels to detect phosphorylated and total ERK, respectively. Western blot analysis of data was normalized to total ERK level and expressed as fold change over the respective basal levels. Each column and the vertical line represent the means 6 SEM (n = 6). Letters above the bars indicate significant differences (P , 0.05) among treatments. Bars with the same letter are not significantly different. One c-Fos mRNA expression, and exocytosis, such as GnRH release, are regulated by different pathways in GnRH neurons. These possibilities should be investigated in future studies.
Interaction between VIP and GnIH signaling pathways
From the opposite effect of GnIH-Rs and VPAC2 toward on intracellular cAMP levels, it is expected that GnIH has an inhibitory effect on downstream signaling of VIP/ VPAC2. Our results clearly show that GnIH suppresses the stimulatory effect of VIP at multiple levels, CRE-mediated activation, MAPK pathway, c-Fos expression, and GnRH release. We suspect that GnIH-Rs may form heterodimers with VPAC2 to interfere with VIPinduced signaling pathway, because it has been suggested that GPCR heteromerization affects the pharmacological and cellular signaling responses. Future studies are needed to investigate whether GnIH-Rs physically interact with VPAC2 in response to VIP and/or GnIH stimulation.
Regulation of c-Fos expression and its relationship with GnRH release
c-Fos is rapidly and transiently expressed in neurons in response to stimulation, thus it has been commonly recognized as the marker of the functional activity of the brain. In this study, c-Fos mRNA expression was clearly induced by 1 h of VIP stimulation via PKA-mediated pathway in GT1-7 cells (Fig. 7 and Supplemental Fig. 3 ). To further investigate whether VIP also activates c-Fos protein expression in GT1-7 cells, we examined the effect of VIP on c-Fos protein level by 10, 30, 60, and 120 min. Although a considerable c-Fos mRNA expression was observed without any stimulation, the basal level of c-Fos protein was barely detectable in GT1-7 cells (Supplemental Fig. 4A, B) . Furthermore, in contrast to mRNA regulation, VIP and the PKA activator FSK did not induce c-Fos protein expression, even if VPAC2 was overexpressed, and only the PKC activator PMA induced a great degree of c-Fos induction peaking at 1 h after exposure (Supplemental Fig. 4A, B) . However, kisspeptin, which activates PKC-related pathway, did not induce c-Fos protein expression either (Supplemental Fig. 4B ), implying that different isoforms of PKC may be involved in c-Fos regulation by PMA.
Although c-Fos protein expression, which is thought to be a neuronal activation marker, was not induced by VIP and kisspeptin in GT1-7 cells, GnRH release was effectively elevated by VIP and kisspeptin in hypothalamic explants (Figs. 1 and 8) , suggesting that c-Fos protein induction is not necessary for GnRH release in 1 h stimulation by VIP or kisspeptin. Notably, GnRH mRNA expression was not affected by 1 h treatment of VIP and kisspeptin in both GT1-7 cells and hypothalamic culture (data not shown). Thus, it is supposed that different regulatory mechanisms may exist in increasing GnRH release: 1) fast response within 1 h, which does not need the activation of c-Fos and GnRH mRNA expression, and 2) relatively long-term response resulting in GnRH mRNA expression via c-Fos activation.
Physiological significance of the inhibitory action of GnIH on GnRH/LH surge
It is hypothesized that VIP input is required for appropriate LH pulse frequencies and induction of an appropriately timed LH surge (31, 46, 47) . The SCN of female rats, compared with males, have significantly greater VIP innervation of GnRH neurons (25) , suggestive of a specific role for VIP in the regulation of estrous cycle. The necessity of VIP in triggering the afternoon GnRH surge has been also suggested (30, 31) . These findings suggest that direct VIP projections from the SCN to GnRH system positively drive the GnRH/LH surge. In addition, vip-null female mice have exhibited some infertility (47, 48) , although vpac2-null mice showed no impairment in fertility (49) . Supporting the sexually dimorphism of VIP input to GnRH neurons, the stimulatory effect of VIP on GnRH release was only observed in hypothalamic culture of female mice (Fig. 8) . Given the pronounced inhibitory actions of GnIH on VIP/VPAC2 signaling in GnRH secreting neurons and VIP-induced GnRH release that was demonstrated in the present study, it seems probable that GnIH may contribute to SCN regulation of the GnRH/LH surge. Supporting this possibility, treatment of female rats with GnIH results in marked inhibition of GnRH neuronal activity at the time of LH surge (16) . From a developmental standpoint, the number of VIP-GnRH contacts increases from prepubertal to adult female rats (50) , and VIP-innervated GnRH neurons exhibit lower activation levels in middle-aged female rats (51), suggesting that VIP may also be involved in the initiation of reproductive senescence. Conversely, both GnIH expression and neuronal activation (GnIH/c-Fos) decrease markedly in the early prepubertal stage in female mice (52) . Recently, Kauffman et al. investigated the effects of VIP and reproductive senescence on GnRH, kisspeptin, and GnIH neurons (53) . They demonstrated that VIP differentially affects activation of GnRH and kisspeptin neurons of female rats in an age-dependent manner, and VIP does not affect GnIH cell number and GnIH mRNA level, or c-Fos expression in GnIH neurons. In their experiments, intracerebroventricular infusion of VIP reduced the percentage of GnRH neurons expressing c-Fos in young females, whereas increased in middle-aged females (53) . On the other hand, in our experiments by directly measuring GnRH release from in vitro culture of female hypothalamic explants, VIP increased GnRH release regardless of age, and the inhibitory effect of GnIH was clearly observed (Fig. 8) . Although Kauffman et al. suspected little possibility of interactions between VIP and GnIH signalings in the neuroendocrine axis of female reproduction, our present study strongly suggests that the inhibitory effect of GnIH is directly on VIP-induced GnRH neuronal activation and eventual GnRH release. Future studies are required to fully investigate the physiological relevance of GnIH inhibition of VIP-induced signaling regulating GnRH/LH surge, or reproductive senescence.
Kisspeptin/GPR54 signaling also plays a critical role in generating the LH surge via activation of GnRH neurons. It has been shown that treatment with GPR54 antagonists or kisspeptin antibody abolishes LH surge (17, 54) . Moreover kiss1-and gpr54-null mice exhibit no or weak LH surge (55, 56) . Because GnIH inhibited kisspeptin action on GnRH release, GnIH may be related in the negative regulation of GnRH/LH surge.
In summary, the present study investigated the effect of GnIH on the signaling pathways leading to the activation of GnRH neurons triggered by kisspeptin and VIP. Although GnIH effectively suppressed the effect of kisspeptin on GnRH release in hypothalamic culture, GnIH did not inhibit kisspeptin/GPR54-mediated signaling pathways in GT1-7 cells. We also clearly demonstrated that GnIH eliminates the stimulatory effect of VIP on GnRH release, and this suppressive effect of GnIH may be mediated by directly inhibition of VIP-induced PKAdependent signaling in GnRH neurons. Overall, our results suggest that GnIH exerts its inhibitory effect by specifically acting via the AC/cAMP/PKA pathway in GnRH neurons as in gonadotropes.
